Clinical Oncology
Volume 24, Issue 1 , Pages 30-38, February 2012

Testing Testes: Problems and Recent Advances in the Diagnosis of Testicular Tumours and Implications for Treatment

  • S.S. Jeetle
  • ,
  • D.M. Berney

      Affiliations

    • Corresponding Author InformationAuthor for correspondence: D.M. Berney, Department of Molecular Oncology, Barts Cancer Institute, John Vane Science Centre, Charterhouse Square, London EC1M 6BQ, UK. Tel: +44-207-882-3551.

The Orchid Tissue Laboratory, Department of Molecular Oncology, Barts Cancer Institute, London, UK

Received 3 May 2011; received in revised form 14 June 2011; accepted 5 July 2011. published online 19 September 2011.

Abstract 

The low incidence of testicular tumours and the fact that they show an extremely high diversity means that they may be poorly understood. Knowledge of the range of tumours and the differences in treatment available is essential for appropriate management. The advent of cisplatin chemotherapy and the exquisite sensitivity of seminoma to radiotherapy have resulted in excellent cure rates. Nevertheless, research has continued unabated, particularly to understand the molecular basis of germ cell tumours and why certain tumours are recalcitrant to treatment. This overview is an attempt to demystify areas of confusion and highlight areas of current interest in testicular pathology and oncology.

Key words: Classification, germ cell tumours, neoplasms, seminoma, teratoma, testis

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0936-6555(11)00791-6

doi:10.1016/j.clon.2011.08.005

Clinical Oncology
Volume 24, Issue 1 , Pages 30-38, February 2012